Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Thrombocythemia, Essential × Docetaxel × 30 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 15 Squamous Cell Carcinoma of Head and Neck 7 Prostatic Neoplasms 7 Lung Neoplasms 6 Breast Neoplasms 6 Urinary Bladder Neoplasms 5 Prostatic Neoplasms, Castration-Resistant 4 Parkinson Disease 4, Autosomal Dominant Lewy Body 4 Carcinoma, Transitional Cell 4 Stomach Neoplasms 3 Ovarian Neoplasms 3 Neoplasms 3 Laryngeal Neoplasms 3 Triple Negative Breast Neoplasms 2 Salivary Gland Neoplasms 2 Oropharyngeal Neoplasms 2 Non-Muscle Invasive Bladder Neoplasms 2 Neoplasm Metastasis 2 Mouth Neoplasms 2 Lymphoid Interstitial Pneumonia 2 Fallopian Tube Neoplasms 2 Endometrial Neoplasms 2 Adenocarcinoma Of Esophagus 2 Vaccinia 1 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Tongue Neoplasms 1 Thyroid Neoplasms 1 Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7 1 Solid Tumor, Adult 1

Interventions

ruxolitinib 3 venetoclax 1 veliparib 1 pevonedistat 1 iadademstat 1 fedratinib 1 decitabine and cedazuridine drug combination 1 bomedemstat 1 Topotecan 1 Specimen Handling 1 Injections 1 INCB057643 1 Decitabine 1 Carboplatin 1 Biopsy 1 Azacitidine 1 Acetylcysteine 1 11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡